(Q35892017)

11 August 2017

A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer (English)

1 reference

11 August 2017

phase III clinical trial

0 references

0 references

1 reference

15

1 reference

11 August 2017

D Piquemal

9

0 references

Pascal Hammel

object named as

P Hammel

16

0 references

Patrice Dubreuil

object named as

P Dubreuil

11

0 references

author name string

G Deplanque

1

1 reference

11 August 2017

M Demarchi

2

1 reference

11 August 2017

M Hebbar

3

1 reference

11 August 2017

P Flynn

4

1 reference

11 August 2017

B Melichar

5

1 reference

11 August 2017

J Atkins

6

1 reference

11 August 2017

E Nowara

7

1 reference

11 August 2017

L Moyé

8

1 reference

11 August 2017

D Ritter

10

1 reference

11 August 2017

C D Mansfield

12

1 reference

11 August 2017

Y Acin

13

1 reference

11 August 2017

A Moussy

14

1 reference

11 August 2017

9 April 2015

1 reference

11 August 2017

1 reference

11 August 2017

26

1 reference

11 August 2017

6

1 reference

11 August 2017

1194-1200

1 reference

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516046

Immune infiltrates as predictive markers of survival in pancreatic cancer patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516046

Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516046

A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516046

Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516046

Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516046

Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse model

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516046

Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516046

Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516046

Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516046

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516046

Diverse responses between human pancreatic cancer cell lines to native alpha 1-antitrypsin and its C-terminal fragment.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4516046

24 September 2018

Identifiers

DOI

10.1093/ANNONC/MDV133

1 reference

11 August 2017

1 reference

11 August 2017

1 reference